These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6128316)

  • 1. Rate of formation of hydrogen peroxide (H2O2) in IUD-fitted human endometrium--a preliminary report.
    Chakraborti AS; Chatterjee P; Dutta S; Dasgupta PR
    Int J Fertil; 1982; 27(3):132-3. PubMed ID: 6128316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The morphologic changes of endometrial hematostatic reaction in intrauterine devices induced menorrhagia].
    Pan J; Yu Y; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):526-9. PubMed ID: 8556910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased fibrinolytic activity in the endometrium of patients using copper-iud (gravigard).
    Larsson B; Liedholm P; Astedt B
    Int J Fertil; 1975; 20(2):77-80. PubMed ID: 3481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menstrual bleeding pattern and iron status in women fitted with copper and non-medicated intrauterine contraceptive devices.
    Oyelola OO; Okonofua FE; Adediran TO
    East Afr Med J; 1994 Apr; 71(4):268-70. PubMed ID: 8062778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer?
    Guleria K; Agarwal N; Mishra K; Gulati R; Mehendiratta A
    J Obstet Gynaecol Res; 2004 Jun; 30(3):181-7. PubMed ID: 15210039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of leukaemia inhibitory factor (LIF) during the window of implantation in copper T380A intrauterine device users.
    Güney M; Oral B; Karahan N; Mungan T
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):212-9. PubMed ID: 17763259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of intrauterine contraceptive device on expression of vascular endothelial growth factor, kinase insert domain-containing receptor and microvessel density in endometrium].
    Xin ZM; Xie QZ; Cao LM; Sun YP; Su YC; Guo YH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):771-5. PubMed ID: 15634506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of hydrogen peroxide in normal and copper-treated rat endometrium.
    Johri RK; Dasgupta PR
    J Reprod Fertil; 1980 Jul; 59(2):495-9. PubMed ID: 7431308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.
    Möller B; Rönnerdag M; Wang G; Odlind V; Olovsson M
    Hum Reprod; 2005 May; 20(5):1410-7. PubMed ID: 15760960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of copper-containing intrauterine contraceptive devices (IUCD) on growth of endometrial and cervical cells.
    Amin NS; Al-janabi NY; Banna HB; Al-tai S; Al-kateeb A; Kubba K; Al-nasiri N
    Med Sci Res; 1989 May 1-15; 17(9):433-4. PubMed ID: 12283436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E (alpha tocopherol) in the management of menorrhagia associated with the use of intrauterine contraceptive devices (IUCD).
    Dasgupta PR; Dutta S; Banerjee P; Majumdar S
    Int J Fertil; 1983; 28(1):55-6. PubMed ID: 6134690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prostaglandins in IUD-associated uterine bleeding--effect of a prostaglandin synthetase inhibitor (ibuprofen).
    Roy S; Shaw ST
    Obstet Gynecol; 1981 Jul; 58(1):101-6. PubMed ID: 7243136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IUD-induced uterine bleeding.
    El-badrawi HH; Hafez ES
    Contracept Deliv Syst; 1980 Oct; 1(4):303-18. PubMed ID: 12262133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicated intrauterine devices: development considerations and clinical uses.
    Chien YW
    J Parenter Drug Assoc; 1980; 34(4):295-323. PubMed ID: 6902777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal profile in IUD users.
    Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
    Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The morphometric study of endometrium during long-term use of TCu220C IUD].
    Zhao Y; He Q
    Zhonghua Fu Chan Ke Za Zhi; 1996 Sep; 31(9):519-22. PubMed ID: 9275420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.